Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 6.24B 926M 801M 747M 687M 1.3B 88.26B 1.31B 8.79B 3.44B 43.95B 3.48B 3.4B 146B P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 7.11B 1.06B 913M 852M 783M 1.48B 101B 1.5B 10.02B 3.92B 50.12B 3.96B 3.88B 166B EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
67.53%
Yield 2024 *
-
Yield 2025 -
1 day-0.44%
1 week+2.47%
Current month-0.65%
1 month-0.22%
3 months-9.15%
6 months+10.12%
Current year+5.06%
1 week 4.52
Extreme 4.52
4.64
1 month 4.36
Extreme 4.36
4.83
Current year 4.08
Extreme 4.08
5.47
1 year 4.08
Extreme 4.08
6.7
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
25.83
Manager TitleAgeSince
Chief Executive Officer 56 02/04/2015
Director of Finance/CFO 41 29/12/2020
Corporate Officer/Principal 42 27/01/2014
Director TitleAgeSince
Chairman 56 27/03/2026
Director/Board Member 58 25/12/2007
Director/Board Member 42 27/01/2014
Date Insider Type Main position Quantity % Market Cap.
21/9/20 Sell

Chairman

1,940,600 0.2495%
18/9/20 Sell

Director

3,670,000 0.4719%
18/9/20 Sell

Chairman

296,500 0.0381%
Change 5-day change 1-year change 3-year change Capi.($)
-0.44%+2.47%-30.02%-44.13% 927M
-1.13%+1.13%-8.15%-3.96% 13.81B
-1.30%+1.34%-29.93%-50.51% 5.3B
-1.44%+5.41%+5.61%+9.42% 5.23B
+0.42%+0.30%+2.69%-31.78% 4.13B
-0.11%+2.24%-2.45%-2.80% 3.75B
-1.75%-2.12%-2.55%+5.14% 3.66B
-0.31%-0.44%-4.86%+15.27% 3.52B
-1.00%-0.69%-14.04%-22.43% 2.49B
-1.17%+2.19%-2.73%+51.63% 1.92B
Average -0.82%-0.28%-8.64%-7.41% 4.47B
Weighted average by Cap. -0.92%-0.23%-7.47%-7.60%

Financials

2024 2025
Net sales 3.83B 568M 491M 458M 421M 797M 54.13B 806M 5.39B 2.11B 26.95B 2.13B 2.08B 89.49B 3.05B 452M 392M 365M 336M 635M 43.14B 642M 4.3B 1.68B 21.48B 1.7B 1.66B 71.32B
Net income 33.62M 4.99M 4.32M 4.03M 3.7M 7M 476M 7.08M 47.38M 18.54M 237M 18.73M 18.32M 787M -104M -15.48M -13.4M -12.5M -11.49M -21.74M -1.48B -21.98M -147M -57.56M -735M -58.15M -56.87M -2.44B
Net Debt 1.4B 208M 180M 168M 154M 292M 19.81B 295M 1.97B 772M 9.87B 780M 763M 32.76B 875M 130M 112M 105M 96.27M 182M 12.38B 184M 1.23B 482M 6.16B 487M 477M 20.46B
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
04/08/26 CNY 4.570 -0.44% 5,390,400
03/08/26 CNY 4.590 -0.22% 5,984,900
31/07/26 CNY 4.600 +0.88% 5,453,800
30/07/26 CNY 4.560 -0.44% 4,385,700
29/07/26 CNY 4.580 +0.88% 5,496,100

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002424 Stock